Advertisement
Advertisement
NRXS
Neuraxis, Inc.
6.26
USDSponsored
-0.02
-0.32%
Aug 18, 15:57 UTC -4
Closed
After-Market
6.28
+0.02
+0.38%
NRXS Earnings Reports
Positive Surprise Ratio
NRXS beat 4 of 10 last estimates.
40%
Next Report
Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.70M
/-$0.11
Implied change from Q2 26 (Revenue/ EPS)
+40.05%
/-42.11%
Implied change from Q3 25 (Revenue/ EPS)
+233.12%
/-54.17%
Neuraxis, Inc. earnings per share and revenue
On Aug 11, 2026, NRXS reported earnings of -0.19 USD per share (EPS) for Q2 26, beating the estimate of -0.32 USD, resulting in a 41.79% surprise. Revenue reached 1.93 million, compared to an expected 2.04 million, with a -5.39% difference. The market reacted with a -7.57% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 2.70 million USD, implying an decrease of -42.11% EPS, and increase of 40.05% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Claritev Corporation
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$4.21
Actual
-$3.49
Surprise
+17.12%
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
CapsoVision, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-12.02%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.23
Surprise
+7.67%
CareCloud, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.06
Actual
$0.06
Surprise
-7.12%
P3 Health Partners Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$1.93
Actual
-$0.63
Surprise
+67.41%
Hims & Hers Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.01
Actual
-$0.10
Surprise
-599.30%
Heartflow, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.07
Surprise
+48.68%
MDxHealth SA Ordinary Shares
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+9.04%
Heartbeam, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.10
Surprise
-8.93%
FAQ
What were Neuraxis, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Neuraxis, Inc. reported EPS of -$0.19, beating estimates by 41.79%, and revenue of $1.93M, -5.39% below expectations.
How did the market react to Neuraxis, Inc.'s Q2 2026 earnings?
The stock price moved down -7.57%, changed from $6.87 before the earnings release to $6.35 the day after.
When is Neuraxis, Inc. expected to report next?
The next earning report is scheduled for Nov 11, 2026.
What are the forecasts for Neuraxis, Inc.'s next earnings report?
Based on 3
analysts, Neuraxis, Inc. is expected to report EPS of -$0.11 and revenue of $2.70M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement